|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV035343354 |
003 |
DE-627 |
005 |
20230624021911.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2016.01.020
|2 doi
|
028 |
5 |
2 |
|a GBVA2016012000020.pica
|
035 |
|
|
|a (DE-627)ELV035343354
|
035 |
|
|
|a (ELSEVIER)S0378-3782(16)30006-8
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Korsten, Koos
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Prediction model of RSV-hospitalization in late preterm infants: An update and validation study
|
264 |
|
1 |
|c 2016
|
300 |
|
|
|a 6
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a New vaccines and RSV therapeutics have been developed in the past decade. With approval of these new pharmaceuticals on the horizon, new challenges lie ahead in selecting the appropriate target population.
|
700 |
1 |
|
|a Blanken, Maarten O.
|4 oth
|
700 |
1 |
|
|a Nibbelke, Elisabeth E.
|4 oth
|
700 |
1 |
|
|a Moons, Karel G.M.
|4 oth
|
700 |
1 |
|
|a Bont, Louis
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:95
|g year:2016
|g pages:35-40
|g extent:6
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2016.01.020
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 95
|j 2016
|h 35-40
|g 6
|
953 |
|
|
|2 045F
|a 610
|